Cargando…

Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors

Genetic susceptibility for xerostomia, a common sequela of radiotherapy and chemoradiotherapy for head and neck cancer, is unknown. Therefore, to identify genetic variants associated with moderate to severe xerostomia, we conducted a GWAS of 359 long-term oropharyngeal cancer (OPC) survivors using 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aggarwal, Puja, Hutcheson, Katherine A., Yu, Robert, Wang, Jian, Fuller, Clifton D., Garden, Adam S., Goepfert, Ryan P., Rigert, Jillian, Mott, Frank E., Lu, Charles, Lai, Stephen Y., Gunn, G. Brandon, Chambers, Mark S., Li, Guojun, Wu, Chih-Chieh, Hanna, Ehab Y., Sturgis, Erich M., Shete, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033773/ https://www.ncbi.nlm.nih.gov/pubmed/35459784 http://dx.doi.org/10.1038/s41598-022-10538-9

Ejemplares similares

Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer
por: Aggarwal, Puja, et al.
Publicado: (2021)

Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
por: Aggarwal, Puja, et al.
Publicado: (2022)

(18)FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer
por: Elhalawani, Hesham, et al.
Publicado: (2021)

Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers
por: Salama, Vivian, et al.
Publicado: (2023)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy
por: Ng, Sweet Ping, et al.
Publicado: (2020)

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer
por: Jensen, Garrett L., et al.
Publicado: (2017)

Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes
por: Gensheimer, Michael F, et al.
Publicado: (2014)

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
por: Eraj, Salman A., et al.
Publicado: (2017)

Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
por: Eraj, Salman A., et al.
Publicado: (2017)

Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort
por: van Dijk, Lisanne V., et al.
Publicado: (2021)

The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors
por: Stieb, Sonja, et al.
Publicado: (2020)

Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21(st) century
por: Garden, Adam S, et al.
Publicado: (2013)

Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients
por: Barua, Souptik, et al.
Publicado: (2021)

A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk of recurrence in patients with oropharyngeal cancer
por: Wang, Chengyuan, et al.
Publicado: (2016)

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
por: Chen, Xingming, et al.
Publicado: (2016)

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer
por: Wang, Zhongqiu, et al.
Publicado: (2012)

Defining the dose‐volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split‐field IMRT, whole‐field IMRT and VMAT
por: Wilke, Christopher, et al.
Publicado: (2020)

The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy
por: Zhang, Hua, et al.
Publicado: (2018)

Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT
por: Mohamed, Abdallah S.R., et al.
Publicado: (2018)

Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer
por: Bahig, Houda, et al.
Publicado: (2021)

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma
por: Elhalawani, Hesham, et al.
Publicado: (2020)

The impact of induction and/or concurrent chemoradiotherapy on acute and late patient‐reported symptoms in oropharyngeal cancer: Application of a mixed‐model analysis of a prospective observational cohort registry
por: van Dijk, Lisanne V., et al.
Publicado: (2021)

Xerostomia after Radiotherapy for Oral and Oropharyngeal Cancer: Increasing Salivary Flow with Tasteless Sugar-free Chewing Gum
por: Kaae, Julie Killerup, et al.
Publicado: (2016)

Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage
por: Kamal, Mona, et al.
Publicado: (2020)

Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma
por: Kamal, Mona, et al.
Publicado: (2019)

Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
por: Stieb, Sonja, et al.
Publicado: (2020)

Saliva substitute mouthwash in nasopharyngeal cancer survivors with xerostomia: a randomized controlled trial
por: Marimuthu, Dayaabaran, et al.
Publicado: (2020)

The Role of Patient- and Treatment-Related Factors and Early Functional Imaging in Late Radiation-Induced Xerostomia in Oropharyngeal Cancer Patients
por: Marzi, Simona, et al.
Publicado: (2021)

Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer
por: Fanizzi, Annarita, et al.
Publicado: (2022)

Xerostomia induced by radiotherapy
por: Alimi, David
Publicado: (2015)

Corrigendum: Transfer learning approach based on computed tomography images for predicting late xerostomia after radiotherapy in patients with oropharyngeal cancer
por: Fanizzi, Annarita, et al.
Publicado: (2022)

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
por: Tsao, Anne S., et al.
Publicado: (2016)

Association between Diet and Xerostomia: Is Xerostomia a Barrier to a Healthy Eating Pattern?
por: Stankeviciene, Indre, et al.
Publicado: (2021)

Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI)
por: Mott, Frank E., et al.
Publicado: (2020)

Diagnosis and management of xerostomia and hyposalivation
por: Villa, Alessandro, et al.
Publicado: (2014)

Xerostomia and Its Cellular Targets
por: Kim, Yoon-Jung
Publicado: (2023)

Manual Therapy for Fibrosis-Related Late Effect Dysphagia in head and neck cancer survivors: the pilot MANTLE trial
por: Hutcheson, Katherine, et al.
Publicado: (2021)

Tratamiento de pacientes con xerostomía
por: Ramos León, Gabriela
Publicado: (2011)

"Xerostomía estado y tratamiento actual"/
por: López alarcón, Juliet
Publicado: (2008)

Xerostomia in a patient with scrub typhus
por: Han, Yeon-Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gtv96lk7f6buvhfvao7b22mi3p